Revolution Medicines (RVMD) Asset Utilization Ratio (2020 - 2024)

Revolution Medicines' Asset Utilization Ratio history runs 5 years deep, the most recent figure standing at 0.0 for Q3 2024.

• On a quarterly basis, Asset Utilization Ratio fell 96.79% year-over-year to 0.0 in Q3 2024; TTM through Sep 2024 was 0.0, a 96.79% decrease from a year earlier, with the FY2023 full-year figure at 0.01, down 82.35% from the prior year.
• Asset Utilization Ratio advanced to 0.0 in Q3 2024 per RVMD's latest filing, from 0.0 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.14 in Q1 2020 and bottomed at 0.0 in Q2 2024.
• The 5-year median for Asset Utilization Ratio is 0.04 (2021), against an average of 0.05.
• Across the five-year window, Asset Utilization Ratio climbed 8.26% in 2022 and tumbled 97.25% in 2024, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.07 in 2020, then sank by 46.04% to 0.04 in 2021, then climbed by 8.26% to 0.04 in 2022, then plunged by 82.4% to 0.01 in 2023, then tumbled by 89.27% to 0.0 in 2024.
• Per Business Quant, the three latest RVMD Asset Utilization Ratio figures stand at 0.0 (Q3 2024), 0.0 (Q2 2024), and 0.0 (Q1 2024).